Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
VILLAMIZAR, Alonso Merchán et al. Achievement of LDL cholesterol targets in patients with coronary artery disease. Rev. Colomb. Cardiol. [online]. 2020, vol.27, n.6, pp.511-516. Epub July 22, 2021. ISSN 0120-5633. https://doi.org/10.1016/j.rccar.2019.10.004.
Introduction:
Patients with established atherosclerotic disease require treatment with statins in order to reduce the probability of new events.
Objective:
To identify the percentage of patients with established atherosclerotic coronary disease that achieve cLDL (LDL - cholesterol) levels less than 70mg/dL, and to describe its distribution in three treatment groups: statins, other lipid lowering drugs, and without treatment.
Methods:
A cross-sectional, descriptive observational study was conducted on patients diagnosed with atherosclerotic disease from 2017 and over 18-years-old from 3 tertiary hospitals. A record was made of the lipid profile that was performed at least three months after the diagnosis.
Results:
A total of 746 patients with atherosclerotic coronary disease were included. The mean age was 65.3±10.9 years and the majority (75.5%) were males. Of the total number of patients evaluated, 97.8% were prescribed a therapy with at least one statin, 0.7% with other lipid-lowering drugs, and 1.5% had no treatment. Just over half (56%) of the patients had cLDL levels of less than 70mg/dL.
Conclusions:
The widespread use of clinical practice guidelines for dyslipidaemias in adults in Colombia, and the incorporation of high-intensity statins, has led to an improvement in the proportion of patients with established atherosclerotic disease achieving cLDL targets. However, a high percentage still does not reach the targets, which suggests a need for an improving of the use of available and recently developed therapies.
Keywords : Statins; Lipid profile targets; Atherosclerotic cardiovascular disease; LDL-Cholesterol.